Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease.

Abstract

AIMS Left ventricular hypertrophy (LVH) is a predictor for cardiovascular mortality, and it is considered to be a surrogate marker of preclinical cardiovascular disease. This study aimed at evaluating whether fetuin-A plasma levels are decreased in patients with moderate chronic kidney disease (CKD) and their linkage to plasma concentrations of hs-C… (More)

Topics

Cite this paper

@article{Cottone2007AssociationBB, title={Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease.}, author={Santina Cottone and Emilio Nardi and Giuseppe Mul{\`e} and Anna Vadal{\`a} and Maria Carmela Lorito and Raffaella Riccobene and Alessandro Palermo and Rosalia Arsena and Marco Guarneri and Giovanni A. Cerasola}, journal={Clinical nephrology}, year={2007}, volume={67 4}, pages={209-16} }